Randomized Phase II Study of First‐Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non‐Small Cell Lung Cancer: LOGIK0801

LESSONS LEARNED: The usefulness of maintenance gemcitabine (GEM) after biweekly carboplatin + GEM in elderly patients with non‐small cell lung cancer could not be proved. Superior overall survival was obtained in the group that did not receive maintenance therapy. BACKGROUND: The primary objective o...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncologist
Auteurs principaux: Takayama, Koichi, Takeshita, Masafumi, Inoue, Koji, Ichiki, Masao, Fujita, Masaki, Harada, Taishi, Shiraishi, Yoshimasa, Wataya, Hiroshi, Tokunaga, Shoji, Yamada, Tadaaki, Uchino, Junji, Sugio, Kenji
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Inc. 2020
Sujets:
Clinical Trial Results
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7418367/
https://ncbi.nlm.nih.gov/pubmed/32385918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0322
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires